Access to early cancer screenings and intervention can reduce deaths by 45%, according to the American Cancer Society. However, accessibility remains a significant challenge.

In this week's episode of "Podnosis," Heather Landi from Fierce Healthcare engages in a conversation with Othman Laraki, co-founder and CEO of Color Health. They delve into strategies for boosting screenings and explore the partnership between Color Health and the American Cancer Society, aimed at making convenient cancer screenings more accessible.

Access to early cancer screenings and intervention can reduce deaths by 45%, according to the American Cancer Society. However, accessibility remains a significant challenge.
In this week's episode of "Podnosis," Heather Landi from Fierce Healthcare engages in a conversation with Othman Laraki, co-founder and CEO of Color Health. They delve into strategies for boosting screenings and explore the partnership between Color Health and the American Cancer Society, aimed at making convenient cancer screenings more accessible.

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

'Podnosis': Breaking down barriers to cancer screenings

In this week’s episode of "Podnosis," you'll hear from two journalists from the Fierce Healthcare team: Paige Minemyer, senior editor of Fierce Health Payer, and Dave Muoio, a staff writer for Fierce Healthcare. Together, they guide you through their key insights from the inaugural Fierce Health Payer Summit in Austin and dive into the latest earnings updates from the largest health plans and health systems.

To learn more about the topics in this episode: 
UnitedHealth sees a 'mixed bag' of responses to GLP-1 demand
CVS Health beats the Street with $2.3B in Q3 profit
Sutter Health slips to 0.1% operating margin, $98M net loss in Q3
Kaiser Permanente logs $239M net income, 0.6% operating margin in Q3 2023
Cigna boosts guidance as it posts $1.4B in profit for Q3
Humana raises MA enrollment projections again, beats EPS market estimates
Community Health Systems brings more physicians in-house to combat high labor costs, staffing fees
UHS beats with $167M Q3 profit, but has more work securing payments, reducing physician expenses on its plate
HCA Healthcare's newly consolidated physician staffing venture is bleeding $50M per quarter, execs tell investors
Centene still expects to lose more than 2M members as Medicaid redeterminations reach midway point
Elevance Health braces for $500M hit to bonus revenue amid MA star ratings drop

In this week’s episode of "Podnosis," you'll hear from two journalists from the Fierce Healthcare team: Paige Minemyer, senior editor of Fierce Health Payer, and Dave Muoio, a staff writer for Fierce Healthcare. Together, they guide you through their key insights from the inaugural Fierce Health Payer Summit in Austin and dive into the latest earnings updates from the largest health plans and health systems.
To learn more about the topics in this episode: 
<ul>
<li><a href="https://www.fiercehealthcare.com/payers/unitedhealth-posts-58b-profit-924b-revenue-q3-beat" data-cke-saved-href="https://www.fiercehealthcare.com/payers/unitedhealth-posts-58b-profit-924b-revenue-q3-beat">UnitedHealth sees a 'mixed bag' of responses to GLP-1 demand</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/cvs-health-beats-street-23b-q3-profit" data-cke-saved-href="https://www.fiercehealthcare.com/payers/cvs-health-beats-street-23b-q3-profit">CVS Health beats the Street with $2.3B in Q3 profit</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/sutter-health-slips-01-operating-margin-98m-net-loss-q3" data-cke-saved-href="https://www.fiercehealthcare.com/providers/sutter-health-slips-01-operating-margin-98m-net-loss-q3">Sutter Health slips to 0.1% operating margin, $98M net loss in Q3</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/kaiser-permanente-logs-239m-net-income-06-operating-margin-q3-2023" data-cke-saved-href="https://www.fiercehealthcare.com/providers/kaiser-permanente-logs-239m-net-income-06-operating-margin-q3-2023">Kaiser Permanente logs $239M net income, 0.6% operating margin in Q3 2023</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/cigna-boosts-guidance-it-posts-14b-profit-q3" data-cke-saved-href="https://www.fiercehealthcare.com/payers/cigna-boosts-guidance-it-posts-14b-profit-q3">Cigna boosts guidance as it posts $1.4B in profit for Q3</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/humana-raises-ma-enrollment-projections-again-beats-eps-market-estimates" data-cke-saved-href="https://www.fiercehealthcare.com/payers/humana-raises-ma-enrollment-projections-again-beats-eps-market-estimates">Humana raises MA enrollment projections again, beats EPS market estimates</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/community-health-systems-stays-red-q3-91m-loss" data-cke-saved-href="https://www.fiercehealthcare.com/providers/community-health-systems-stays-red-q3-91m-loss">Community Health Systems brings more physicians in-house to combat high labor costs, staffing fees</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/universal-health-services-beats-estimates-167m-profit-q3-2023" data-cke-saved-href="https://www.fiercehealthcare.com/providers/universal-health-services-beats-estimates-167m-profit-q3-2023">UHS beats with $167M Q3 profit, but has more work securing payments, reducing physician expenses on its plate</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/hca-healthcare-reports-11b-net-income-rising-volumes-q3-2023" data-cke-saved-href="https://www.fiercehealthcare.com/providers/hca-healthcare-reports-11b-net-income-rising-volumes-q3-2023">HCA Healthcare's newly consolidated physician staffing venture is bleeding $50M per quarter, execs tell investors</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/centene-boosts-guidance-back-469m-q3-profit" data-cke-saved-href="https://www.fiercehealthcare.com/payers/centene-boosts-guidance-back-469m-q3-profit">Centene still expects to lose more than 2M members as Medicaid redeterminations reach midway point</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/elevance-health-boosts-guidance-it-posts-13b-q3-profit" data-cke-saved-href="https://www.fiercehealthcare.com/payers/elevance-health-boosts-guidance-it-posts-13b-q3-profit">Elevance Health braces for $500M hit to bonus revenue amid MA star ratings drop</a></li>
</ul>

'Podnosis': A deep dive into Q3 earnings, and key takeaways from the Fierce Health Payer Summit

Hello Heart, a digital platform designed to help people manage their heart health, is a U.S.-based company with offices in California and New York, and it also has a significant presence in Israel, with the majority of its roughly 80 employees there working from the Tel Aviv office.  

In this week’s episode of “Podnosis,” Hello Heart CEO Maayan Cohen, who resides in Tel Aviv, shares her personal experience during a challenging moment when she was on her way to the annual HLTH conference in Las Vegas and heard about the October 7th attack by Hamas on Israel. At that moment, Cohen was unable to help get her employees, some of whom were in the strike zone, to safety. She sat down with Fierce’s Anastassia Gliadkovskaya to talk about what she did next and her strategy for leading Hello Heart through the crisis. 

Hello Heart, a digital platform designed to help people manage their heart health, is a U.S.-based company with offices in California and New York, and it also has a significant presence in Israel, with the majority of its roughly 80 employees there working from the Tel Aviv office.  
In this week’s episode of “Podnosis,” Hello Heart CEO Maayan Cohen, who resides in Tel Aviv, shares her personal experience during a challenging moment when she was on her way to the annual HLTH conference in Las Vegas and heard about the October 7th attack by Hamas on Israel. At that moment, Cohen was unable to help get her employees, some of whom were in the strike zone, to safety. She sat down with Fierce’s Anastassia Gliadkovskaya to talk about what she did next and her strategy for leading Hello Heart through the crisis.

'Podnosis': Leading with empathy amid crisis

In this week's episode of “Podnosis,” we explore Blue Shield of California's plan to transform its pharmacy model. This includes a shift away from the traditional PBM relationship in favor of forming partnerships with five companies: Amazon Pharmacy, Abarca, Mark Cuban Cost Plus Drugs Company, CVS Caremark and Prime Therapeutics. 

Fierce's Paige Minemyer sat down with Blue Shield of California's Chief Operating Officer, Sandra Clarke, to discuss the new approach to pharmacy benefits. 

To learn more about the topics in this episode: 
PBMs under fire again as Senate introduces new bill
Blue Shield of California ditches CVS Caremark as PBM, unveils new pharmacy care model
Blue Shield of California bringing Wellvolution program to Medi-Cal plans

In this week's episode of “Podnosis,” we explore Blue Shield of California's plan to transform its pharmacy model. This includes a shift away from the traditional PBM relationship in favor of forming partnerships with five companies: Amazon Pharmacy, Abarca, Mark Cuban Cost Plus Drugs Company, CVS Caremark and Prime Therapeutics. 
Fierce's Paige Minemyer sat down with Blue Shield of California's Chief Operating Officer, Sandra Clarke, to discuss the new approach to pharmacy benefits. 
To learn more about the topics in this episode: 
<ul>
<li><a href="https://www.fiercehealthcare.com/payers/pbms-under-fire-again-senate-introduces-new-bill">PBMs under fire again as Senate introduces new bill</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/blue-shield-california-seeks-bypass-pbms-and-overturn-current-drug-pricing-system">Blue Shield of California ditches CVS Caremark as PBM, unveils new pharmacy care model</a></li>
<li><a href="https://www.fiercehealthcare.com/payers/blue-shield-california-bringing-wellvolution-program-medi-cal-plans">Blue Shield of California bringing Wellvolution program to Medi-Cal plans</a></li>
</ul>

'Podnosis': Breaking down barriers to cancer screenings

In 1 playlist(s)

Podnosis

Social links

Follow podcast

Recent clips